Daxor to present at the inaugural h.c. wainwright bioconnect 2021 conference

New york, jan. 08, 2021 (globe newswire) -- daxor corporation (nyse mkt: dxr), the global leader in blood volume measurement technology (organized as an investment company with fully-owned innovative medical instrumentation and biotechnology operations), today announces that michael feldschuh, daxor's president & chief executive officer, will present at the inaugural h.c. wainwright bioconnect investment conference which is being held from january 11th to 14th through a virtual format with on-demand video presentations.
DXR Ratings Summary
DXR Quant Ranking